Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
RGN-259 treatment promoted rapid healing of corneal epithelial defects, improved Mackie classification disease stage, and produced significant improvements in ocular discomfort, foreign body sensation, and dryness, with no significant adverse effects
second vial covers margin and fresh reconstitution
Conditions Treated by IV Therapy IV therapy tackles dehydration, fatigue, migraines, and hangovers
Food & Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease
US$ 27.18
US$ 27.60
US$ 27.62
US$ 26.77
US$ 27.98
US$ 25.06
US$ 28.20
US$ 24.13
